PAIN
Volume 137, Issue 2 , Pages 276-285 , 15 July 2008

Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain

  • Dennis C. Turk

      Affiliations

    • University of Washington, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Anesthesiology, Box 356540, University of Washington, Seattle, WA 98195, USA. Tel.: +1 206 616 2626; fax: +1 206 543 2958.
    • ,
  • Robert H. Dworkin

      Affiliations

    • University of Rochester, Rochester, NY, USA
    • ,
  • Dennis Revicki

      Affiliations

    • United BioSource Corporation, Bethesda, MD, USA
    • ,
  • Gale Harding

      Affiliations

    • United BioSource Corporation, Bethesda, MD, USA
    • ,
  • Laurie B. Burke

      Affiliations

    • United States Food and Drug Administration, Rockville, MD, USA
    • ,
  • David Cella

      Affiliations

    • Northwestern University, Chicago, IL, USA
    • ,
  • Charles S. Cleeland

      Affiliations

    • MD Anderson Cancer Center, Houston, TX, USA
    • ,
  • Penney Cowan

      Affiliations

    • American Chronic Pain Association, Rocklin, CA, USA
    • ,
  • John T. Farrar

      Affiliations

    • University of Pennsylvania, Philadelphia, PA, USA
    • ,
  • Sharon Hertz

      Affiliations

    • United States Food and Drug Administration, Rockville, MD, USA
    • ,
  • Mitchell B. Max

      Affiliations

    • National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    • ,
  • Bob A. Rappaport

      Affiliations

    • United States Food and Drug Administration, Rockville, MD, USA

Received 22 May 2007 ,Revised 22 August 2007 ,Accepted 4 September 2007.

References 

  1. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. PRO Harmonization Group. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6:522–531
  2. Babbie E. The practice of social research. 6th ed.. Belmont, CA: Wadsworth Publishing Company; 1992;
  3. Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.. J Rheumatol. 1997;24:799–802
  4. Broderick JE, Stone AA, Calvanese P, Schwartz JE, Turk DC. Recalled pain ratings: a complex and poorly defined task. J Pain. 2006;7:142–149
  5. In:  Carr DB,  Loeser JD,  Morris DB editor. Narrative, pain, and suffering. Progress in pain research and management. Vol. 34:Seattle: IASP Press; 2005;
  6. Casarett D, Karlawish J, Sankar P, Hirschman K, Asch DA. Designing pain research from the patient’s perspective: what trial end points are important to patients with chronic pain. Pain Med. 2001;2:309–316
  7. Clark P, Lavielle P, Martinez H. Learning from pain scales: patient perspective. J Rheumatol. 2003;30:1584–1588
  8. Cleeland CS. Measurement of pain by subjective report. In:  Chapman CR,  Loeser JD editor. Issues in pain measurement. Advances in pain research and therapy. Vol. 12:New York: Raven Press; 1989;p. 391–403
  9. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med. 1994;23:129–138
  10. Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpaa M, Jorum E, et al. EFNS guidelines for neuropathic pain assessment. Eur J Neurol. 2004;11:153–162
  11. Deyo RA, Battie M, Beurskens AH, Bomardier C, Croft P, Koes B, et al. Outcome measures for low back pain research: a proposal for standardized use. Spine. 1998;23:2003–2013
  12. In:  Dworkin RH,  Breitbart WS editor. Psychosocial aspects of pain: a handbook for health care providers. Seattle, WA: IASP Press; 2004;
  13. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9–19
  14. In:  Gatchel RJ,  Turk DC editor. Psychosocial factors in pain: critical perspectives. New York: Guilford Press; 1999;
  15. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23:345–356
  16. Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, et al. Lessons learned from a multiple-dose postoperative analgesic trial. Pain. 2004;109:103–109
  17. National Center for Health Statistics. National Health Interview Survey, 1986: Interviewer’s manual. HIS-100. Hyattsville, MD: National Center for Health Statistics, 1987.
  18. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61:277–284
  19. Palos GR, Mendoza TR, Mobley GM, Cantor SB, Cleeland CS. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006;7:49–56
  20. Polit DR, Hungler BP. Nursing research: principles and methods. Philadelphia, PA: JB Lipincott Company; 1995;
  21. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9:887–900
  22. Robinson ME, Brown JL, George SZ, Edwards PS, Atchison JW, Hirsh AT, et al. Multidimensional success criteria and expectations for treatment for chronic pain: the patient perspective. Pain Med. 2005;6:336–345
  23. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–345
  24. Turk DC, Flor H. Chronic pain: a biobehavioral perspective. In:  Gatchel RJ,  Turk DC editor. Psychosocial factors in pain: critical perspectives. New York: Guilford Press; 1999;p. 18–34
  25. Turk DC, Okifuji A. Pain assessment. Lancet. 1999;353:1784–1788
  26. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, and U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Health and Quality of Life Outcomes 2006, 4:79. See also FDA- Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims – Draft guidance. 2005 [<http://www.fda.gov/cder/guidance/5460dft.pdf>].
  27. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  28. Zelman DC, Dukes E, Brandenburg N, Bostrom A, Gore M. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain. 2005;115:29–36

PII: S0304-3959(07)00503-9

doi: 10.1016/j.pain.2007.09.002

PAIN
Volume 137, Issue 2 , Pages 276-285 , 15 July 2008

Article Tools